Literature DB >> 28207105

Coagulation factor levels in non-metastatic colorectal cancer patients.

S Battistelli1, M Stefanoni, B Lorenzi, R Dell'Avanzato, F Varrone, A Pascucci, R Petrioli, Vittoria Vittoria.   

Abstract

There is evidence that high plasma levels of factor (F) VIII, FIX, FXI and fibrinogen are independent risk factors for venous thromboembolism. AIM: To determine the plasma concentrations of several coagulation factors and C4b-binding protein (C4BP) in a group of patients with non-metastatic colorectal cancer in order to investigate some aspects of cancer-acquired thrombophilia.
METHODS: Plasma fibrinogen, FII, FV, FVII, FVIII, FIX, FX, FXI and FXII activity levels and C4BP concentrations were determined in 73 patients with non-metastatic colorectal cancer (48 colon and 25 rectum) and in 67 matched control subjects. No one in either group had had previous thrombotic events.
RESULTS: Mean plasma concentrations of fibrinogen (functional and antigen), FVIII, FIX, FV and C4BP were significantly higher in colorectal cancer patients than in control subjects, while FVII and FXII levels were significantly decreased. Several correlations were found between the increased coagulation factors and C4BP concentrations, while FVII was highly correlated with FXII.
CONCLUSIONS: In colorectal cancer patients high plasma fibrinogen, FVIII and FIX levels might represent further risk factors for venous thrombotic complications in the immediate post-surgery period, while decreased FVII and FXII concentrations may be an index of intravascular coagulation activation, still in a subclinical phase.

Entities:  

Year:  2008        PMID: 28207105     DOI: 10.5301/JBM.2008.4255

Source DB:  PubMed          Journal:  Int J Biol Markers        ISSN: 0393-6155            Impact factor:   2.659


  5 in total

Review 1.  The coagulome and the oncomir: impact of cancer-associated haemostatic dysregulation on the risk of metastasis.

Authors:  Kate Burbury; Michael P MacManus
Journal:  Clin Exp Metastasis       Date:  2018-02-28       Impact factor: 5.150

2.  Plasma levels of phospholipase A2-IIA in patients with different types of malignancies: prognosis and association with inflammatory and coagulation biomarkers.

Authors:  Mario Menschikowski; Albert Hagelgans; Ulrich Schuler; Susanne Froeschke; Andrea Rosner; Gabriele Siegert
Journal:  Pathol Oncol Res       Date:  2013-06-01       Impact factor: 3.201

3.  Identification of Novel Autoantibodies Based on the Human Proteomic Chips and Evaluation of Their Performance in the Detection of Gastric Cancer.

Authors:  Chi Cui; Yaru Duan; Cuipeng Qiu; Peng Wang; Guiying Sun; Hua Ye; Liping Dai; Zhuo Han; Chunhua Song; Kaijuan Wang; Jianxiang Shi; Jianying Zhang
Journal:  Front Oncol       Date:  2021-02-26       Impact factor: 6.244

Review 4.  "Complimenting the Complement": Mechanistic Insights and Opportunities for Therapeutics in Hepatocellular Carcinoma.

Authors:  Astha Malik; Unmesha Thanekar; Surya Amarachintha; Reena Mourya; Shreya Nalluri; Alexander Bondoc; Pranavkumar Shivakumar
Journal:  Front Oncol       Date:  2021-02-24       Impact factor: 5.738

5.  F12 as a reliable diagnostic and prognostic biomarker associated with immune infiltration in papillary thyroid cancer.

Authors:  Jun-Hua Luo; Xiu-Xia Zhang; Wu-Hui Sun
Journal:  Aging (Albany NY)       Date:  2022-04-28       Impact factor: 5.682

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.